THE STEM CELL & TURMERIC RESEARCH REPORT
Few people are aware of the more than 4400 government trials that have been in progress using adult stem cellsfor more than 87 major diseases.The documented current stem cell progressis nothing short of incredible. Thefull colorChristian Wilde Stem Cell and Turmeric Research Report has been informing families of the ongoingpromise of stem cell researchandwhat exciting breakthroughs lie aheadto help your family or friends live longer healthier lives.
The growing body of scientific evidence on the benefits of turmeric is now a regular ongoing part of the report. It is now the Christian Wilde Stem Cell and Turmeric Research Report. The information is astounding.
DISEASESCOVEREDIN ISSUE ONE (issues 1-4)
Diabetes I, breast cancer, macular degeneration, retinitis pigmentosa, stroke damage, (MS) multiple sclerosis, Parkinson's, osteo and rheumatoid arthritis. The recruiting heart failure trials. Stem cells now available for animals*
DISEASES IN ISSUE TWO
Alzheimer's disease, diabetes II, spinal injury, kidney disease, HIV, cerebral palsy, autism and more ...
DISEASES IN ISSUE THREE
Lymphomas and lukemias, brain cancer, prostate cancer, bone and ligament disease, liver disease. Preventive and protective properties of turmeric/curcumin.
DISEASES IN ISSUE FOUR
Ovarian cancer, crohn's corneal regeneration, systemic Lupus. (Building organs with stem cells forhearts, tracheas, livers, kidneys.) Enrolling centers for heart failure patients and storage of umbilical cords.
DISEASES IN ISSUE FIVE (ordering issues 5-8)
Aortic Valve, Non Surgical Replacement, Stem cell trials for MS, Turmeric for pancreatic cancer, Updates on turmeric and diseases, EMBRYONIC VS ADULT STEM CELLS, Stem cells for Parkinson's AND MORE.
DISEASES IN ISSUE SIX
Fibromyalgia, Stem Cells for MD, Stem cells for arthritic damage. First success for Pulmonary hypertension. Reversing Type I and II diabetes, + Surprise interviews with trial leaders and an interview with one of17 patients actuallyhealed for(3 full years) of Relapsing, Remitting Multiple Sclerosis. Five leading cancers in US compared to India where turmeric is consumed in the diet. Arthritic damage and stem cells. Dr. Paul Ridker from Harvard (father of inflammation) makes Time Magazine's top 10.
DISEASES INISSUE 7
A comprehensive study and report on howall types of cancer are benefiting from turmeric/curcumin both as a preventive and for existing cancer. In order to bring you the most accurate scientific information on this spice and how it does what it does, the world leader in the research who has conducted many of the trials for breast, pancreatic and other cancer trials has been a contributing source. There will also be some major breakthrough news on stem cells but the emphasis in this issue will be turmeric's curcumin for fighting all inflammatory diseases.
DISEASES IN ISSUE 8
Interview with Dr. Carlos Lima who has performed 150 successful spinal cord stem cell surgeries. Turmeric for heart disease, Stem cells for the heart, Women and Turmeric, a 4 heart attack patient (renewed with stem cells) interviewed. How Stem cells will favorably impact health costs.
DISEASESIN ISSUE 9 (issues 9-12)
Stem cells for face lifts. Single cell grows prostate gland. Stem cells for baldness also stem cells for ALS. Amit Patel, M.D., Director Cardiovascular and Stem Cell Researchat University of Utah performs first time procedure and saves Coast to Coast listener who had 7 heart attacks. Alzheimer's and dementia discussion of the 7 stages and what is available for the fight. Also what is normal aging behavior and what is a warning sign. Much more!
DISEASES IN ISSUE 10
FIRSTstem cell trial for degenerative back disease. First trial for stroke victim recovery. Turmeric for breast cancer. Stem cells for cartilage. Turmeric for liver and prostate. Stem cells for newborns of drug addicted mothers. Stem cells for Parkinson's disease.
DISEASES IN ISSUE 11
HIV patient cured of AIDS,Stem Cells for Vision, Stem Cells Building Lungs,Turmeric for better Chemo results, Breakthroughs for Parkinson's, Building body parts, Stem Cells for deadly infections AND MORE.
DISEASES IN ISSUE 12
Three stem cell trials for eyes, insulin from cord blood, Teeth Stem Cells may heal brain, New MS study, Melanoma breakthrough, Stem Cells double muscle size for elderly, Progress report on Stem Cell research.
DISEASES IN ISSUE 13
Major cancer breakthrough, Stem Cells for brain cancer, Turmeric reduces stroke damage, Salute to a stem cell Pioneer, Dr. Amit Patel, Stem Cell Spray for Burn Victims using stem cells. Progressive MS Study, Stem Cells for family pets. Fewer aputations for diabetics, Fat Cells for breast reconstruction, Big Pharma making drugs from turmeric.
DISEASES IN ISSUE 14
Storing new borns umbilical cords for stem cells, Creating actual body parts in regenerative medicine, A 1st time reversal of Cystic Fibrosis, Stem Cells save Pro Pitcher's Arm, more on MS, Arthritis and joint damage repair, Kidneys and livers, Bone cartilage and joints, Correcting blindness in infants. Vatica financing adult stem cell research.
DISEASES IN ISSUE 15
Stem Cell war against 23 autoimmune diseases, awarded 1 of the top ten breakthroughs of the decade. Top athletes like Peyton Manning, Jason Kidd healing sports injuries with adult stem cells. Turmeric for brain cancers and gliomas. Stem cells building human body parts now. Dental Pulp to heal brains? Turmeric for kidneys.
DISEASES IN ISSUE 16
Stem Cell progress, Where are we? Sir Ian Wilmut cloned Dolly The Sheep now favors (iPSCs)Induced Pluripotent stem cells as the best answer for cures. First embryonic stem cell terminated because of tumors. Stem Cell hope to end Tissue Rejection. Most promising back stem cell trial, can it help you?
THE QUARTERLY STEM CELL REPORTMAY BE ORDERED ONLINE BY CLICKINGON THE ABOVE COLORED IMAGE
OR BY SENDING A CHECK OR MONEY ORDER FOR ONE YEAR FOR$19.95 ALONG WITH $2.50 S/H. TOTAL ONEYEAR PRICE IS $22.45 CA RESIDENTS KINDLY ADD $1.89 CA TX .
TO WILDE RESEARCH REPORT, P.O. BOX 1363, STUDIO CITY, CA 91614.You will receive all issues you order at one time.
SPECIFY WHICHCOMBINATION OF 4 ISSUESYOU WOULD LIKE --All16 issues are $79.80.
ORDERING OPTION, YOU MAY ALSO ORDER BY CALLING TOLL FREE, 1 866 STEM 123 AND LEAVE A MESSAGE FOR AN OFFICE CALL BACK TO TAKE YOUR ORDER.
* STEM CELLS FOR PETS*
YOUR dogs, cats and horsescancurrentlyreceive treatment with stem cells! Thesetreatments are not subject to FDA trial approval and are available now! The report will share information on how to contact the company that will direct you to veterinarians in your area who are certified and trained to perform stem cell treatment for your pet. Hip dysplasia, osteoarthritis, bone/ ligament disease,kidney and liverdisease (as examples) may be helped.
Disclaimer: The information presented in the newsletter is not to be misconstrued as endorsement or recommendation by the author or the reportfor any trial or therapy. It is acknowledged, many of these treatments are experimental and exploratory, therefore the information is presented to inform you as to what is being studied within the research communitythat might favorably impact yourcondition.Yourphysicianis your best arbiter andit is advisable to alwaysconsult with him or heron all decisions particularly with exploratory treatments.
Sincerely yours, Christian Wilde
Christian Wilde, "Hidden Causes of Heart Attack" and "Mir.
Go here to read the rest:
Stem Cell Heart Regeneration - Turmeric Curcumin Benefits ...
- Hannah just thought she was being clumsy, but her bruises were a sign she needed to see her doctor - Daily Mail - October 27th, 2023
- Brent Rutemiller's Cancer In Early Remission After 42 Weeks of Chemotherapy and Stem Cell Transplant - Swimming World Magazine - May 20th, 2022
- Other Notable Health Studies & Research From May 17, 2022 - Study Finds - May 20th, 2022
- Clinton County Relay For Life holds annual event in Riverview Park - Lock Haven Express - May 20th, 2022
- Illinois Is Being Invaded By Worms That Jump A Foot In The Air - 1440wrok.com - May 20th, 2022
- Moderna, J&J COVID Booster Shots Near Authorization. Here's What to Know - NBC Chicago - October 26th, 2021
- GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF- R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research -... - October 26th, 2021
- Merck Provides Update on KEYTRUDA (pembrolizumab) Indication in Third-Line Gastric Cancer in the US - Business Wire - July 6th, 2021
- Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene - GlobeNewswire - July 6th, 2021
- New global guidelines for stem cell research aim to drive discussions, not lay down the law - The Conversation AU - May 27th, 2021
- Merck (MRK) Granted Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy - StreetInsider.com - May 27th, 2021
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal... - May 27th, 2021
- Epigenetic therapies for heart failure | VHRM - Dove Medical Press - May 27th, 2021
- OPDIVO (nivolumab) in Combination with CABOMETYX (cabozantinib) Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for... - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Opdivo in Combination with Cabometyx Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced RCC -... - February 14th, 2021
- Astellas and Seagen Announce Presentation of Results from PADCEV (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced... - February 14th, 2021
- [Full text] Loganin Attenuates Septic Acute Renal Injury with the Participation of | DDDT - Dove Medical Press - February 14th, 2021
- [Full text] Encephalopathy Induced by Preventive Administration of Acyclovir in a | IJGM - Dove Medical Press - February 14th, 2021
- Joint inflammation: Causes, treatment, and symptoms - Medical News Today - February 14th, 2021
- Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz Therapeutic Activity - PRNewswire - February 3rd, 2021
- How Coronavirus Damages Lung Cells Within Mere Hours And What Drugs Could Halt COVID-19 Infection - SciTechDaily - February 3rd, 2021
- Mini kidneys bioprinted in the lab - Lab + Life Scientist - December 4th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - December 4th, 2020
- News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug -... - December 4th, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - Philippine Canadian... - December 4th, 2020
- Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic... - November 11th, 2020
- KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Demonstrated Statistically Significant Improvement in Progression-Free Survival (PFS), Overall... - November 11th, 2020
- Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 - Investing News Network - November 11th, 2020
- The great reset: new danger on the horizon - Amandala - November 11th, 2020
- Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come - Seeking Alpha - November 11th, 2020
- COVID Drug Given to Trump Developed From Aborted Fetus Cells - Quint Fit - October 10th, 2020
- Lars Jaeger: The Future is Veggie, With 3D Printing - finews.asia - October 10th, 2020
- Laid off from ImmunoGen, an ex-Genzyme and Shire exec heads to an ARCH upstart - Endpoints News - October 10th, 2020
- 5 Deadly Pre-existing Conditions You Could Have Due To COVID-19 - Brumpost - Brumpost - October 10th, 2020
- The Crypto Daily Movers and Shakers October 10th, 2020 - Sports Grind Entertainment - October 10th, 2020
- Coronavirus Tracker: Bexar Co. cases surpass 59,000; Texas hospitalizations trending in the wrong direction - KENS5.com - October 10th, 2020
- Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million - Business Wire - September 24th, 2020
- Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations - BioSpace - September 15th, 2020
- Alexion and Caelum Biosciences Announce Start of Phase 3 Studies of CAEL-101 in AL Amyloidosis - Business Wire - September 15th, 2020
- Braunstein Reflects on the Rise of Quadruplet Therapies in Multiple Myeloma - OncLive - September 9th, 2020
- Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients - GlobeNewswire - September 9th, 2020
- ASX Biotechs Surfing The Covid Story - FN Arena News - August 16th, 2020
- Merck and Eisai Receive Complete Response Letter for KEYTRUDA (pembrolizumab) plus LENVIMA (lenvatinib) Combination as First-Line Treatment for... - July 10th, 2020
- FDA Approves Talaris Therapeutics' IND for Its Allogeneic Cell Therapy FCR001 to Be Evaluated in Patients With a Severe Form of Scleroderma - Business... - July 10th, 2020
- Coronavirus PPP Loans In Livingston: Where The Money Went - Livingston, NJ Patch - July 9th, 2020
- Stem Cell Therapy For Kidney Failure. Learn More Now ... - July 7th, 2020
- Anemia in chronic kidney disease - kidneyfund.org - July 7th, 2020
- Dr Borehams Crucible: Mesoblast within months of 3 major trial results, key regulatory decision - Stockhead - July 7th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -... - June 30th, 2020
- R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico - PR Web - June 30th, 2020
- Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - Stockhouse - June 30th, 2020
- FDA Approves Merck's KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that... - June 25th, 2020
- Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System - Business Wire - June 25th, 2020
- First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer - Science Times - May 27th, 2020
- Scientists generate millions of mature human cells, far more than have ever been produced - UB News Center - May 20th, 2020
- Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo - Medical Daily - May 20th, 2020
- Cell therapies trial planned for COVID-19 - Mirage News - May 5th, 2020
- New Study Finds That Wearing Contact Lenses Doesn't Increase Risk of COVID-19 Infection - HealthDay Coronavirus Liveblog - April 26th, 2020
- Israeli COVID-19 treatment with 100% survival rate tested on US patient - The Jerusalem Post - April 15th, 2020
- Stem Cells and Chronic Kidney Disease | Mayo Clinic Center ... - April 11th, 2020
- Kidney Failure | Stem Cell Treatment in Tijuana Mexico - April 11th, 2020
- MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND... - April 11th, 2020
- Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type - Benzinga - April 11th, 2020
- A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. - Columbia Daily Herald - April 7th, 2020
- Researchers test drug that stops early stages of COVID-19 - Open Access Government - April 7th, 2020
- Can cell-based therapy be helpful in tackling coronavirus? - YourStory - March 25th, 2020
- Made-in-space organs could soon be reality - ETHealthworld.com - March 13th, 2020
- What Is the Coronavirus? - WIRED - March 6th, 2020
- 34 years with a new heart and counting - MDJOnline.com - February 25th, 2020
- Coronavirus: Doctors try 3,000-year-old Traditional Chinese Medicine (TCM) to treat the virus - Times of India - February 20th, 2020
- Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for... - February 14th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 14th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Cambridge Science Festival showcases new research at the forefront of healthcare and medicine - Cambridge Network - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 8th, 2020
- 4 Crazy but Effective Ways to Save More Money This Year - Nasdaq - February 4th, 2020
- BAME lives to be saved as new organ donation law rolls out - Keep the Faith - January 15th, 2020
- HIV drug resistance an emerging threat, expert warns - DAWN.com - January 10th, 2020
- A Lasting Legacy: DuPont, C8 Contamination and the Community Left to Grapple With the Consequences - alleghenyfront.org - January 10th, 2020